USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.78 | $-0.80 | $-0.80 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $0.00 | $0.00 | $0.00 |
Gossamer Bio's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 6 | $-0.76 | $-0.84 | $-0.62 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 7 | $-3.12 | $-3.19 | $-3.02 |
| Dec 2022 | 8 | $-2.94 | $-3.50 | $-2.42 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.75 | $-0.73 | $-0.72 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-3.11 | $-3.08 | $-3.09 |
| Dec 2022 | 0 / 0 | $-2.94 | $-3.03 | $-3.05 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $0.00 | $0.00 | $0.00 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 8 | $0.00 | $0.00 | $0.00 |
| Dec 2022 | 8 | $0.00 | $0.00 | $0.00 |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.78 | - | - |
| Aug 9, 2021 | Jun 2021 | $-0.76 | $-0.80 | -5.61% |
| May 6, 2021 | Mar 2021 | $-0.77 | $-0.78 | -1.96% |
| Feb 25, 2021 | Dec 2020 | $-0.79 | $-0.88 | -11.68% |
| Nov 10, 2020 | Sep 2020 | $-0.84 | $-0.80 | 5.21% |
| Aug 11, 2020 | Jun 2020 | $-0.82 | $-1.00 | -21.65% |
| May 12, 2020 | Mar 2020 | $-0.75 | $-0.87 | -16.00% |
| Mar 24, 2020 | Dec 2019 | $-0.82 | $-0.89 | -8.80% |
| Nov 12, 2019 | Sep 2019 | $-0.70 | $-0.80 | -15.11% |
| Aug 8, 2019 | Jun 2019 | $-0.56 | $-0.74 | -32.14% |
| May 14, 2019 | Mar 2019 | $-0.66 | $-0.90 | -37.40% |
| Mar 22, 2019 | Dec 2018 | $-1.37 | $-1.39 | -1.46% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 25, 2021 | Dec 2020 | $-3.50 | $-3.55 | - |
| Mar 24, 2020 | Dec 2019 | $-3.18 | $-3.33 | - |
| Mar 22, 2019 | Dec 2018 | $-4.65 | $-1.39 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $0.00 | - | - |
| Aug 9, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 6, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Feb 25, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Nov 10, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 11, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| May 12, 2020 | Mar 2020 | $0.00 | $0.00 | - |
| Mar 24, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Nov 12, 2019 | Sep 2019 | $0.00 | $0.00 | - |
| Aug 8, 2019 | Jun 2019 | $0.00 | $0.00 | - |
| May 14, 2019 | Mar 2019 | $0.00 | $0.00 | - |
| Mar 22, 2019 | Dec 2018 | $0.00 | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 25, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Mar 24, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Mar 22, 2019 | Dec 2018 | $0.00 | $0.00 | - |
GOSS's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 6 analysts, the average EPS estimation for Gossamer Bio's next quarterly earnings is $-0.78, with a low EPS estimation of $-0.82, and a high estimation of $-0.74.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.79, the last 2 month trend is $-0.79, and the 3 month trend is $-0.76.
Based on 3 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.
Gossamer Bio's previous earnings date was Aug 9, 2021 for its fiscal quarter ended Jun 30, 2021.
GOSS's earnings per share (EPS) was $-0.80, missing the consensus analysts forecast of $-0.76 by -5.61%.
The EPS was lower than the previous fiscal quarter (Mar 2021) by 2.56%, and higher than the same period a year before (Jun 2020) by -20.00%.
Revenues were $0.00.
The company reported a net income of $-59.83M.Free cash flow for the quarter was $-47.60M , compared to $-59.73M last quarter and $-57.84M a year before.
GOSS ended the quarter with $185.24M in total debt, an increase of 0.42% compared to the previous quarter, and a decrease of -34.70% compared to the same quarter a year before.
Gossamer Bio's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.
GOSS's earnings per share (EPS) was $-3.55, missing the consensus analysts forecast of $-3.50 by 1.43% , and lower than the previous year's EPS (Dec 2019) by 6.61%.
Revenues were $0.00.
The company reported a net income of $-243.36M.
Gossamer Bio reported a free cash flow of $-201.24M for its fiscal year, compared to $-151.40M a year ago.
The company ended the fiscal year with $176.02M in total debt, an increase of 471.25% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.